secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2022-10-28T23:59:59+00:00
Accession:  0001493152-22-029839
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience FY2022 revenue down 51% to $1.8M; net loss widens to $3.5M
--------------------------------------------------------------------------

- Net product sales of $1.81M vs $3.70M in FY2021; royalties fell to $40K from $229K.
- Net loss of $3.5M ($0.04/sh) compared to $2.3M ($0.03/sh) in prior year.
- Net loss excluding stock compensation was $2.9M; cash used in operations $2.5M.
- Sales team expanded: three street execs, Midwest manager, two AVP corporate accounts.
- CRM software implemented; two-team sales approach targeting janitorial and sanitation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315222029839/0001493152-22-029839-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315222029839/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-029839

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer